Long noncoding RNA ZFAS1: A novel anti-apoptotic target in Fuchs endothelial corneal dystrophy

Exp Eye Res. 2024 Apr:241:109832. doi: 10.1016/j.exer.2024.109832. Epub 2024 Feb 17.

Abstract

Fuchs endothelial corneal dystrophy (FECD) is the leading cause of endothelial keratoplasty without efficacious drug treatment. Recent studies have emphasized the involvement of epigenetic regulation in FECD development. Long non-coding RNAs (lncRNAs) are recognized as crucial epigenetic regulators in diverse cellular processes and ocular diseases. In this study, we revealed the expression patterns of lncRNAs using high-throughput sequencing technology in FECD mouse model, and identified 979 significantly dysregulated lncRNAs. By comparing the data from FECD human cell model, we obtained a series of homologous lncRNAs with similar expression patterns, and revealed that these homologous lncRNAs were enriched in FECD related biological functions, with apoptosis (mmu04210) showing the highest enrichment score. In addition, we investigated the role of lncRNA zinc finger antisense 1 (ZFAS1) in apoptotic process. This study would broaden our understanding of epigenetic regulation in FECD development, and provide potential anti-apoptotic targets for FECD therapy.

Keywords: Apoptosis; Epigenetics; FECD; LncRNA ZFAS1.

MeSH terms

  • Animals
  • Endothelium, Corneal / metabolism
  • Epigenesis, Genetic
  • Fuchs' Endothelial Dystrophy* / genetics
  • Fuchs' Endothelial Dystrophy* / metabolism
  • Humans
  • Mice
  • RNA, Long Noncoding* / genetics
  • Zinc / metabolism

Substances

  • RNA, Long Noncoding
  • Zinc
  • ZFAS1 long non-coding RNA, human